Texas Gov. Abbott orders state agencies to divest from China

22.11.24 20:17 Uhr

Werte in diesem Artikel
Aktien

108,06 EUR -0,10 EUR -0,09%

Indizes

PKT PKT

19.572,6 PKT 199,8 PKT 1,03%

16.393,8 PKT 170,4 PKT 1,05%

2.915,8 PKT 28,3 PKT 0,98%

5.930,9 PKT 63,8 PKT 1,09%

Texas Gov. Greg Abbott has ordered all agencies in the state to stop investing in China and to sell off any holdings as soon as possible, citing financial and security risks.In a letter dated Nov. 21, Abbott said "belligerent actions" of the Chinese Communist Party (CCP) "across the Southeastern Pacific region and the world" had increased risks to Texas' investments in China, and told investors to get out."I direct Texas investing entities that you are prohibited from making any new investments of state funds in China," the Republican wrote. "To the extent you have any current investments in China, you are required to divest at the first available opportunity."The state of Texas has been taking an increasingly activist stance in its agencies' investments, having previously restricted public pension funds from doing business with Wall Street firms that have embraced environmental, social and governance principles.STATE LEADERS URGED TO DIVEST PENSION FUNDS FROM CHINA: WATCHDOGIts state agencies include the Teacher Retirement System of Texas, which had $210.5 billion under management at the end of August, according to its annual report.The TRS has roughly $1.4 billion exposure to Chinese yuan and Hong Kong dollar assets, and listed Tencent Holdings as its 10th largest position, worth about $385 million at current prices.Abbott's letter said he had told the University of Texas/Texas A&M Investment Management Company (UTIMCO), which manages nearly $80 billion, to divest from China earlier this year.US COMPANIES WITH HIGH CHINA EXPOSURE FACE MORE RISKSThe Texas governor has warned repeatedly that China is a rising threat to the U.S.During an interview on "Mornings with Maria" last year, Abbott discussed Latin American countries becoming increasingly dependent on China and the lasting impact it could have on Texas as well as the U.S."China is really coming in and changing the attitudes now of Central and South American countries," Abbott said, suggesting that the U.S. adversary's influence over the "entire region around the southern part of the United States" is "quite alarming."GET FOX BUSINESS ON THE GO BY CLICKING HEREIn an op-ed published on Fox News days earlier, Abbott argued that "China’s sights are firmly set" on our southern neighbors as Texas stands at the "gateway of our nation and Latin American countries" as a trading partner.Reuters and FOX Business' Alicia Warren contributed to this report.Weiter zum vollständigen Artikel bei FOX Business

Ausgewählte Hebelprodukte auf Abbott Laboratories

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Abbott Laboratories

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: FOX Business

Nachrichten zu Abbott Laboratories

Analysen zu Abbott Laboratories

DatumRatingAnalyst
27.08.2020Abbott Laboratories SellGoldman Sachs Group Inc.
16.10.2018Abbott Laboratories OverweightBarclays Capital
25.01.2018Abbott Laboratories BuyStifel, Nicolaus & Co., Inc.
15.12.2017Abbott Laboratories OutperformBMO Capital Markets
19.10.2017Abbott Laboratories BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
16.10.2018Abbott Laboratories OverweightBarclays Capital
25.01.2018Abbott Laboratories BuyStifel, Nicolaus & Co., Inc.
15.12.2017Abbott Laboratories OutperformBMO Capital Markets
19.10.2017Abbott Laboratories BuyStifel, Nicolaus & Co., Inc.
19.10.2017Abbott Laboratories OutperformRBC Capital Markets
DatumRatingAnalyst
23.07.2015Abbott Laboratories Equal WeightBarclays Capital
27.03.2015Abbott Laboratories Equal WeightBarclays Capital
30.01.2015Abbott Laboratories Equal WeightBarclays Capital
07.01.2013Abbott Laboratories haltenDeutsche Bank Securities
29.11.2012Abbott Laboratories neutralSarasin Research
DatumRatingAnalyst
27.08.2020Abbott Laboratories SellGoldman Sachs Group Inc.
25.10.2011Abbott Laboratories sellCitigroup Corp.
05.10.2011Abbott Laboratories sellCitigroup Corp.
22.11.2006Advanced Medical Optics sellCitigroup
11.09.2006Abbott Laboratories reduceUBS

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Abbott Laboratories nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"